Department of Surgery, South Auckland Clinical Campus, The University of Auckland, Middlemore Hospital, Auckland, New Zealand.
Department of Surgery, South Auckland Clinical Campus, The University of Auckland, Middlemore Hospital, Auckland, New Zealand.
Surgery. 2022 Jul;172(1):41-52. doi: 10.1016/j.surg.2021.11.030. Epub 2022 Jan 5.
There are multiple treatments for anal fissures. These range from medical treatment to surgical procedures, such as sphincterotomy. The aim of this study was to compare the relative clinical outcomes and effectiveness of interventional treatments for anal fissure.
Randomized controlled trials were identified by means of a PRISMA-compliant systematic review using the Medline, EMBASE, and CENTRAL databases. Inclusion criteria were randomized controlled trials comparing treatments for anal fissure. A Bayesian network meta-analysis was performed using BUGSnet package in R. Outcomes of interest were healing (6-8-, 10-16-, and >16-week follow-up), symptom recurrence, pain (measured on a visual analog scale), and fecal or flatus incontinence. PROPSERO Registration: CRD42021229615.
Sixty-nine randomized controlled trials were included in the analysis. Lateral sphincterotomy remains the treatment with the highest odds of healing compared to botulinum toxin and medical therapy at all follow-up time points. There was no significant difference in healing between botulinum toxin and medical therapy at any time point. Advancement flap showed similar effectiveness compared to lateral sphincterotomy. Medical treatment and botulinum toxin had the highest pain scores at follow-up. Sphincterotomy had the highest odds of fecal and flatus incontinence.
Lateral sphincterotomy had the highest rates of healing and should be considered as the definitive treatment after failed initial therapy with botulinum toxin or medical treatment. Botulinum toxin was equally effective compared to medical treatment. Advancement flap shows similar effectiveness compared to lateral sphincterotomy, but more studies are needed to evaluate its efficacy.
肛门裂有多种治疗方法。这些方法包括从药物治疗到手术治疗,如括约肌切开术。本研究旨在比较肛门裂的介入治疗的相对临床结果和效果。
通过符合 PRISMA 标准的系统评价,使用 Medline、EMBASE 和 CENTRAL 数据库,确定了随机对照试验。纳入标准为比较治疗肛门裂的随机对照试验。使用 R 中的 BUGSnet 包进行贝叶斯网络荟萃分析。感兴趣的结局包括愈合(6-8、10-16 和>16 周随访)、症状复发、疼痛(视觉模拟评分)和粪便或气体失禁。PROPSERO 注册:CRD42021229615。
69 项随机对照试验纳入分析。与肉毒毒素和药物治疗相比,外侧括约肌切开术在所有随访时间点的愈合几率最高。在任何时间点,肉毒毒素和药物治疗之间的愈合率均无显著差异。推进皮瓣与外侧括约肌切开术的疗效相似。药物治疗和肉毒毒素在随访时的疼痛评分最高。括约肌切开术发生粪便和气体失禁的几率最高。
外侧括约肌切开术的愈合率最高,应作为初始治疗失败后采用肉毒毒素或药物治疗的确定性治疗方法。肉毒毒素与药物治疗同样有效。推进皮瓣与外侧括约肌切开术的疗效相似,但需要更多研究来评估其疗效。